Lipid Metabolism Practice Questions

Q: The reducing equivalents for cholesterol biosynthesis are provided by which molecule?

NADPH. ### Explanation **1. Why NADPH is the Correct Answer** Cholesterol biosynthesis is a highly reductive anabolic process occurring primarily in the cytosol and endoplasmic reticulum. The synthesis of one molecule of cholesterol requires **28 molecules of NADPH**. * **Mechanism:** NADPH acts as the essential electron donor (reducing equivalent) at multiple steps, most notably the **rate-limiting step** catalyzed by **HMG-CoA Reductase**, which converts HMG-CoA to Mevalonate. * **Sources of NADPH:** In the liver (the primary site of cholesterol synthesis), NADPH is mainly supplied by the **Pentose Phosphate Pathway (HMP Shunt)** and the **Malic Enzyme** reaction. **2. Why Other Options are Incorrect** * **NADH (Option C):** While NADH is a major electron carrier, it is primarily used in **catabolic** pathways (like Glycolysis and the TCA cycle) to generate ATP via the electron transport chain. It is generally not used for reductive biosynthesis. * **FADH2 & FMNH2 (Options A & B):** These are prosthetic groups involved in redox reactions within the mitochondria (e.g., Beta-oxidation, TCA cycle, and Complex II of ETC). They do not provide the reducing power required for the cytosolic enzymes of cholesterol synthesis. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Rate-Limiting Enzyme:** HMG-CoA Reductase (Target of **Statin** drugs). * **Location:** Occurs in the cytosol and microsomal fraction (ER). * **Precursor:** All 27 carbon atoms of cholesterol are derived from **Acetyl-CoA**. * **Key Intermediate:** **Squalene** is the first 30-carbon hydrocarbon formed in the pathway. * **Rule of Thumb:** Remember that **"NADPH is for Building (Anabolism), NADH is for Burning (Catabolism)."** Other pathways requiring NADPH include Fatty Acid synthesis, Steroidogenesis, and Glutathione reduction.

Q: Which receptors are present in the liver for the uptake of LDL?

Apolipoprotein E and Apolipoprotein B100. **Explanation:** The **LDL receptor (LDLR)**, also known as the **Apo B100/E receptor**, is a cell surface glycoprotein primarily expressed in the liver. It is responsible for the clearance of cholesterol-rich lipoproteins from the plasma. **Why Option C is correct:** The LDL receptor has a high affinity for two specific ligands: 1. **Apolipoprotein B100:** Found on LDL and VLDL. This is the primary ligand for the uptake of LDL particles. 2. **Apolipoprotein E:** Found on IDL (Intermediate-Density Lipoprotein) and Chylomicron remnants. Because the receptor recognizes both proteins to facilitate endocytosis, it is functionally defined by its interaction with both Apo B100 and Apo E. **Analysis of Incorrect Options:** * **Option A:** Apo E alone is the primary ligand for the **LRP (LDL Receptor-Related Protein)**, which clears chylomicron remnants, but it does not account for the uptake of LDL (which lacks Apo E). * **Option B:** Apo A is associated with HDL (High-Density Lipoprotein) and interacts with ABCA1/SR-B1 receptors, not the LDL receptor. * **Option D:** While Apo B100 is the ligand on LDL, the receptor itself is structurally capable of binding both B100 and E; therefore, "B100 and E" is the more complete biochemical description of the receptor's specificity. **High-Yield Clinical Pearls for NEET-PG:** * **Familial Hypercholesterolemia (Type IIa):** Caused by a genetic defect or deficiency in the LDL (B100/E) receptors, leading to severely elevated serum LDL and premature atherosclerosis. * **PCSK9 Inhibitors:** These drugs prevent the degradation of LDL receptors, increasing their recycling to the cell surface and lowering plasma LDL levels. * **Statins:** Work by inhibiting HMG-CoA reductase, which decreases intracellular cholesterol, leading to the **upregulation of LDL receptors** in the liver.

Q: What is the true function of apoprotein CII?

Increases the activity of lipoprotein lipase. **Explanation:** **Apoprotein CII (Apo C-II)** is a crucial cofactor in lipid metabolism. It is primarily found on the surface of **Chylomicrons** and **Very Low-Density Lipoproteins (VLDL)**. 1. **Why Option C is Correct:** The primary physiological role of Apo C-II is to act as a potent **activator of Lipoprotein Lipase (LPL)**. LPL is an enzyme located on the capillary endothelial walls of adipose tissue and muscle. When Apo C-II binds to LPL, it triggers the hydrolysis of triglycerides within the core of chylomicrons and VLDL into free fatty acids and glycerol, allowing tissues to utilize or store the fat. 2. **Why Other Options are Incorrect:** * **Option A & D:** Cholesterol and fatty acid synthesis are intracellular enzymatic processes (primarily in the liver and cytoplasm) regulated by enzymes like HMG-CoA reductase and Fatty Acid Synthase, respectively. Apoproteins are structural or regulatory components of circulating lipoproteins, not enzymes for synthesis. * **Option B:** While Apo C-II is *carried* on transport particles, the specific function of "transport" is attributed to the lipoprotein particle as a whole (and structural proteins like Apo B-48 or B-100), not specifically to the C-II cofactor. **High-Yield Clinical Pearls for NEET-PG:** * **Deficiency:** A genetic deficiency of either Apo C-II or LPL leads to **Type I Hyperlipoproteinemia (Familial Chylomicronemia Syndrome)**, characterized by severe hypertriglyceridemia, eruptive xanthomas, and recurrent pancreatitis. * **Source:** Apo C-II is donated to nascent chylomicrons and VLDL by **HDL** in the circulation. * **Antagonist:** **Apo C-III** acts as an inhibitor of LPL, opposing the action of Apo C-II.

Q: Which cholesterol is designated as "Good Cholesterol"?

HDL. **Explanation:** **HDL (High-Density Lipoprotein)** is designated as "Good Cholesterol" because of its role in **Reverse Cholesterol Transport**. It picks up excess cholesterol from peripheral tissues and blood vessel walls (including atherosclerotic plaques) and transports it back to the liver for excretion in bile. This process prevents lipid accumulation in the arteries, thereby reducing the risk of atherosclerosis and coronary artery disease. **Analysis of Incorrect Options:** * **LDL (Low-Density Lipoprotein):** Known as "Bad Cholesterol." It transports cholesterol from the liver to peripheral tissues. High levels lead to cholesterol deposition in arterial walls, forming plaques. * **VLDL (Very Low-Density Lipoprotein):** Primarily carries endogenous triglycerides from the liver to peripheral tissues. It is a precursor to LDL and is considered pro-atherogenic. * **IDL (Intermediate-Density Lipoprotein):** Formed during the degradation of VLDL. It is transient and eventually converted into LDL; elevated levels also contribute to cardiovascular risk. **High-Yield Clinical Pearls for NEET-PG:** * **ApoA-I:** The major apoprotein associated with HDL (activates LCAT). * **LCAT (Lecithin-Cholesterol Acyltransferase):** The enzyme responsible for esterifying cholesterol within HDL, converting "nascent" discoid HDL into "mature" spherical HDL. * **CETP (Cholesterol Ester Transfer Protein):** Mediates the exchange of cholesterol esters from HDL for triglycerides from VLDL/LDL. * **Protective Levels:** HDL levels >60 mg/dL are considered cardio-protective, while <40 mg/dL is a major risk factor for heart disease.

Q: Which of the following is NOT a constituent of glycosphingolipid?

Glycerol. **Explanation:** The core concept tested here is the structural classification of lipids. Lipids are broadly divided into **glycerophospholipids** (glycerol-based) and **sphingolipids** (sphingosine-based). **Why Glycerol is the correct answer:** Glycosphingolipids belong to the sphingolipid family. Their structural backbone is **Ceramide**, which consists of a long-chain amino alcohol called **sphingosine** attached to a **fatty acid** via an amide bond. In glycosphingolipids, a **carbohydrate** (monosaccharide or oligosaccharide) is attached to the primary hydroxyl group of ceramide. **Glycerol** is the backbone for triglycerides and phospholipids (like lecithin), but it is entirely absent in sphingolipids. **Analysis of Incorrect Options:** * **A. Sphingosine:** This is the 18-carbon amino alcohol that serves as the fundamental structural framework for all sphingolipids. * **B. Fatty Acid:** A long-chain fatty acid is attached to the amino group of sphingosine to form Ceramide, the parent compound of glycosphingolipids. * **D. Carbohydrate:** By definition, "glyco-" refers to the sugar component (e.g., glucose in glucocerebroside or complex oligosaccharides in gangliosides) attached to the ceramide. **High-Yield Clinical Pearls for NEET-PG:** * **Ceramide** = Sphingosine + Fatty acid. * **Cerebroside** = Ceramide + Single sugar (Glucose or Galactose). * **Ganglioside** = Ceramide + Oligosaccharide + **Sialic acid (NANA)**. * **Sphingomyelin** is the only sphingolipid that is a phospholipid (contains phosphate) but NOT a glycolipid. * **Clinical Correlation:** Deficiencies in lysosomal enzymes that degrade glycosphingolipids lead to **Sphingolipidoses** (e.g., Gaucher’s, Niemann-Pick, and Tay-Sachs disease).

Q: Phospholipids are classified as which type of lipid?

Compound lipids. ### Explanation **Correct Answer: C. Compound lipids** **Understanding the Concept:** Lipids are classified based on their chemical composition. **Compound (or complex) lipids** are esters of fatty acids with alcohols that contain **additional groups** such as phosphate, nitrogenous bases, carbohydrates, or proteins. Phospholipids are the most important members of this group. They consist of a glycerol or sphingosine backbone, two fatty acids, and a phosphoric acid residue often linked to a nitrogenous base (like choline in Lecithin). Because they contain this additional phosphoric acid group, they are categorized as compound lipids. **Analysis of Incorrect Options:** * **A. Simple lipids:** These are esters of fatty acids with various alcohols but contain **no other groups**. Examples include Triacylglycerols (fats and oils) and Waxes. * **B. Derived lipids:** These are substances produced by the **hydrolysis** of simple and compound lipids. They include fatty acids, glycerol, steroids (like cholesterol), lipid-soluble vitamins, and hormones. * **D. None of the above:** Incorrect, as phospholipids fit the specific definition of compound lipids. **NEET-PG High-Yield Pearls:** * **Amphipathic Nature:** Phospholipids have both a hydrophilic (polar) head and a hydrophobic (non-polar) tail, making them the structural backbone of biological membranes. * **Lecithin (Phosphatidylcholine):** The most abundant phospholipid in the cell membrane. * **Dipalmitoyl Lecithin:** Acts as a **lung surfactant**. Deficiency in premature infants leads to Respiratory Distress Syndrome (RDS). * **Sphingomyelin:** The only phospholipid that does not contain glycerol (it contains the amino alcohol sphingosine); it is essential for the myelin sheath of nerve fibers.

Q: Where is apolipoprotein A primarily found?

Chylomicrons. ### Explanation **Apolipoprotein B-48 (Apo B-48)** is the structural hallmark of **Chylomicrons**. It is synthesized exclusively in the enterocytes of the small intestine. #### Why Chylomicrons is the Correct Answer: Apo B-48 is a truncated version of Apo B-100 (containing only the N-terminal 48% of the protein). This truncation occurs due to **post-transcriptional RNA editing** by the enzyme *cytidine deaminase*, which introduces a premature stop codon in the mRNA. Because this process is specific to the intestinal mucosa, Apo B-48 is found only in chylomicrons and their remnants, serving as a marker for exogenous (dietary) lipid transport. #### Why Other Options are Incorrect: * **VLDL (Option B):** These are synthesized in the liver and contain **Apo B-100**, not Apo B-48. Apo B-100 is required for VLDL assembly and acts as a ligand for the LDL receptor. * **LDL (Option C):** LDL is the end product of VLDL metabolism. It retains the **Apo B-100** from its parent VLDL molecule. * **HDL (Option D):** HDL does not contain Apo B. Its primary structural protein is **Apo A-I**, which is involved in reverse cholesterol transport. #### High-Yield NEET-PG Pearls: * **RNA Editing:** The conversion of Apo B-100 mRNA to Apo B-48 mRNA is a classic example of tissue-specific RNA editing (C to U transition). * **Abetalipoproteinemia:** A deficiency in **Microsomal Triglyceride Transfer Protein (MTP)** leads to an inability to load Apo B with lipids, resulting in the absence of Chylomicrons, VLDL, and LDL. * **Apo B-48 vs. B-100:** Remember: **B-48** is for the **B**owel (Chylomicrons); **B-100** is for the **L**iver (VLDL/LDL).

Question 1

The reducing equivalents for cholesterol biosynthesis are provided by which molecule?

Accepted Answer

NADPH

Answer

FADH2

Answer

FMNH2

Answer

NADH

Question 2

Which receptors are present in the liver for the uptake of LDL?

Accepted Answer

Apolipoprotein E and Apolipoprotein B100

Answer

Apolipoprotein E

Answer

Apolipoprotein A and Apolipoprotein E

Answer

Apolipoprotein B100

Question 3

What is the true function of apoprotein CII?

Accepted Answer

Increases the activity of lipoprotein lipase

Answer

Cholesterol synthesis

Answer

Triglyceride transport

Answer

Fatty acid synthesis

Question 4

Which cholesterol is designated as "Good Cholesterol"?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

IDL

Question 5

Increased formation of ketone bodies during fasting is a result of?

Accepted Answer

Increased levels of free fatty acids in blood

Answer

Decreased level of circulating glucagon

Answer

Decreased formation of Acetyl CoA in the liver

Answer

Inhibition of beta-oxidation of fatty acids in the liver

Question 6

All of the following statements are true regarding lipoproteins except:

Accepted Answer

Increased blood cholesterol is associated with increased LDL receptors.

Answer

VLDL transports endogenous lipids.

Answer

LDL transports lipids to the tissues.

Answer

Increased HDL is associated with decreased risk of coronary disease.

Question 7

What is the major lipid component of lipoproteins?

Accepted Answer

Arachidonic acid

Answer

Oleic acid

Answer

Palmitic acid

Answer

Linoleic acid

Question 8

Which of the following is NOT a constituent of glycosphingolipid?

Accepted Answer

Glycerol

Answer

Sphingosine

Answer

Fatty acid

Answer

Carbohydrate

Question 9

Phospholipids are classified as which type of lipid?

Accepted Answer

Compound lipids

Answer

Simple lipids

Answer

Derived lipids

Answer

None of the above

Question 10

Where is apolipoprotein A primarily found?

Accepted Answer

Chylomicrons

Answer

VLDL

Answer

HDL

Answer

LDL

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?